News
The extension was needed to review newly submitted long-term clinical data for all patients in the pivotal study following an FDA information request.
Within the past few years, models that can predict the structure or function of proteins have been widely used for a variety ...
Event highlights San Diego’s vital role in biotech innovation and UC San Diego’s commitment to research, patients and ...
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...
The FDA has approved Insmed’s Brinsupri™ (brensocatib 10 mg and 25 mg tablets) as the first drug authorized to treat ...
G Biology." The space tech company just raised $187M to expand its mission of creating pharmaceuticals in low-Earth orbit.
Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...
RED BANK, NEW JERSEY / ACCESS Newswire / August 13, 2025 / Tharimmune, Inc. (Nasdaq:THAR) (“Tharimmune” or the “Company”), a clinical-stage biotechnology company dedicated to developing innovative ...
4d
FDA sends warning to 5 sunscreen brands including Supergoop — why they could be pulled from shelves
The alert follows a wave of warning letters the agency sent to Supergoop!, Vacation Inc. and three other popular brands, ...
Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved ...
Net loss (GAAP) narrowed to $6.1 million in Q2 2025, a 22.8% improvement from the prior-year period, driven by reduced research and development spending. No product revenue reported; The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback